跳至主要内容
临床试验/NL-OMON54197
NL-OMON54197招募中不适用

Detection of recirculating tumor-associated tissue macrophages and circulating melanoma cells as a tool for monitoring melanoma patients: a pilot study. - MelanoScan

Immunologie0 个研究点目标入组 2 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
2

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 64(—)

入选标准

  • General: • At least 18 years old • Able to understand the patient information • Diagnosed with, or a lesion high likelihood of, a cutaneous melanoma Phase 1: • Skin lesion with a diameter of >1 cm, highly likely of melanoma or loco-regional metastases, including local recurrences and in-transit metastasis or hematogenic or lymphogenic metastasis. Phase 2A: • Bulky lymph node disease who undergo debulking surgery. Phase 2B: • Hematogenic or lymphogenic metastasis who undergo debulking surgery. Phase 3: • Different control groups: lichen planus, psoriasis, dermatitis, vitiligo, atopic eczema, and individuals with >100 moles.

排除标准

  • Immune disorders other than stated in the control groups
  • Patients undergoing systemic cytotoxic or immunosuppressant therapy
  • Uveal or mucosal melanoma
  • Anamnestic pregnancy

研究者

发起方
Immunologie

相似试验

Detection of recirculating tumor-associated tissue... | 临床试验